Drug intelligence / Profile preview

LR20024

Development stage: Unknown
Lead developer: LG Chem
Administration: Local Dermal Injection

Overview

LR20024 is a hyaluronic acid (HA) based dermal filler currently under development by LG Chem (CHEMS). It is designed as a medical device for aesthetic and dermal augmentation procedures. The product is administered via local dermal injection to provide physical volume and structural support to the skin, correcting wrinkles, folds, or volume loss. As of 2024, LR20024 is in Phase 2 clinical development, expanding LG Chem's portfolio of HA-based aesthetic products.

Beyond the preview

Go deeper on LR20024.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LR20024.

Explore the full profile